Peri-Implant Diseases and Host Inflammatory Response Involving Mast Cells: A Review

Abstract

Mast cells (MCs) are motile granule-containing cells that originate from bone marrow pluripotential haematopoietic cells, circulate in blood and extravasate in tissues where they play an important role in inflammation, host defense and tissue repair. We herein review the English literature over the past twenty years concerning the biology and function of MCs with particular focus on their role in the inflammatory process in dental implant failure due to osseointegration absence or to peri-implantitis. Due to immunological or non-immunological stimulation, in a few minutes MCs release prestored granule-associated mediators into the extracellular environment promoting pro-/anti-inflammatory events/response. MCs can either protect the host by activating defense mechanisms and initiating tissue repair and osseointegration if their function is transient, or lead to considerable tissue damage if it is inappropriate and continuous leading to osseointegration absence or peri-implantitis. We hypothesize that administration of histamine receptor antagonists, serine protease inhibitors and MC preformed mediator release inhibitors before and after implantation could represent novel therapeutic strategies to improve the osseointegration, the functionality and longevity of implants or prevent and treat peri-implant inflammatory conditions.

Keywords

peri-implantitis mast cells inflammation cytokines immune response

References

Tonetti

Schmid

. Pathogenesis of implant failures. Periodontol 2000 1994; 4:127–38.

Esposito

Hirsh

Lekholm

Thomsen

. Differential diagnosis and treatment strategies for biological complication and failing oral implants. A review of the literature. Int J Oral Maxillofac Implants 1999; 14:473–90.

Piattelli

Scarano

Favero

Iezzi

Petrone

Favero

. Clinical and biologic aspects of dental implants removed due to mobility. J Periodontol 2003; 4:385–90.

Galli

Tsai

. Mast cells: Versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci 2008; 49:7–19.

Crivellato

Beltrami

Mallardi

Ribatti

. Paul Ehrlich's doctoral thesis: a milestone in the study of mast cells. Br J Haematol 2003; 123:19–21.

Walsh

. Mast cells and oral inflammation. Crit Rev Oral Biol Med 2003; 14:188–98.

Irani

Bradford

Kepley

Schechter

Schwartz

. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 1989; 37:1509–15.

Galli

Nakae

Tsai

. Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6:135–42.

Gauchat

Henchoz

Mazzei

. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365:40–3.

10.

Shibli

Melo

Ferrari

Figueiredo

Faveri

Feres

. Composition of supra- and subgingival biofilm of subjects with healthy and diseased implants. Clin Oral Implants Res 2008; 19:975–82.

11.

Taubman

Kawai

. Involvement of T-Lymphocytes in Periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 2001; 12:125–35.

12.

Gemmell

Carter

Seymour

. Mast cells in human periodontal disease. J Dent Res 2004; 83:384–7.

13.

Berglundh

Donati

. Aspects of adaptive host response in periodontitis. J Clin Periodontol 2005; 32:87–107.

14.

Kubes

Kanwar

. Histamine induces leukocyte rolling in post-capillary venules. A P-selectin-mediated event. J Immunol 1994; 152:3570–77.

15.

Tang

Jennings

Eaton

. Mast cells mediate acute inflammatory responses to implanted biomaterials (histamine-phagocytes). Proc Natl Acad Sci USA 1998; 95:8841–46.

16.

Zdolsek

Eaton

Tang

. Histamine release and fibrinogen adsorption mediate acute inflammatory responses to biomaterial implants in humans. J Transl Med 2007; 5:31–38.

17.

Minami

Kuroishi

Ozawa

Shimauchi

Endo

Sugawara

. Histamine amplifies immune response of gingival fibroblasts. J Dent Res 2007; 86: 1083–88.

18.

Gutierréz-Venegas

Arrieta

Villeda-Navarro

Jr Méndez-Mejía

Jr . Histamine promotes the expression of receptors TLR2 and TLR4 and amplifies sensitivity to lipopolysacch aride and lipoteichoic acid treatment in human gingival fibroblasts. Cell Biol Int 2011; Epub ahead of print.

19.

Shoji

Yoshida

Endo

Sasano

. Lipopolysaccharide stimulates histamine-forming enzyme (histidine decarboxylase) activity in murine dental pulp and gingiva. Arch Oral Biol 2006; 51: 856–60.

20.

Takashiba

Naruishi

Murayama

. Perspective of cytokine regulation for periodontal treatment: fibroblast biology. J Periodontol 2003; 74:103–10.

21.

Malaviya

Ikeda

Ross

Abraham

. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996; 381:77–80.

22.

Gemmell

Carter

Seymour

. Chemokines in human periodontal disease tissues. Clin Exp Immunol 2001; 125:134–41.

23.

Preshaw

Taylor

. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol 2011; 38:60–84.

24.

Al-Saffar

Iwaki

Revell

. Direct activation of mast cells by prosthetic biomaterial particles. J Mater Sci Mater Med 1998; 9:849–53.

25.

Mathur

Michalowicz

VBS

. Cell-mediated immune system regulation in periodontal diseases. Crit Rev Oral Biol Med 1997; 8:76–89.

26.

Karulin

Hesse

Yip

Lehmann

. Indirect IL-4 Pathway in Type 1 Immunity. J Immunol 2002; 168:545–53.

27.

Wang

Angkasekwinai

. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007; 204:1837–47.

28.

Zhao

Oskeritzian

Pozez

Schwartz

. Cytokine production by skin-derived mast cells endogenous proteases are responsible for degradation of cytokines. J Immunol 2005; 175:2635–42.

29.

Henz

Maurer

Lippert

Worm

Babina

. Mast cells as initiators of immunity and host defense. Exp Dermatol 2001; 10:1–10.

30.

Kotowicz

Dixon

Klein

Peters

Callard

. Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes. Immunol 2000; 100:441–8.

31.

Lee

Fitzgerald

Huang

Chi

Milhorn

Krishnaswamy

. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta. Am J Respir Cell Mol Biol 2004; 31:283–91.

32.

Silva

Garlet

Fukada

Silva

and Cunha

. Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 2007; 86:306–19.

33.

Watanabe

Kukita

Wada

Toh

Nagata

Nomiyama

Iijima

. Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J Endocrinology 2004; 180:193–201.

34.

Katsanos

Anogeianaki

Orso

Tetè

Salini

Antinolfi

Sabatino

. Mast cells and chemokines. Biol Regul Homeost Agents 2008; 22: 145–51.

35.

Rani

MacDougall

. Dental cells express factors that regulate bone resorption. Mol Cell Biol Res Commun 2000; 3:145–52.

36.

Aslam

Gaça

Buckley

Hollenberg

Walls

. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release. J Pharmacol Exp Ther 2004; 309:119–26.

37.

Holzhausen

Spolidorio

Vergnolle

. Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats. J Dent Res 2005; 84:154–59.

38.

Katada

Muramatsu

Hayashi

Tsutsumi

Konishi

Majima

. Significance of vascular endothelial cell growth factor upregulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J Pharmacol Exp Ther 2002; 302:949–56.

39.

Zhao

Sugerman

Savage

Walsh

. A fluorometric microassay for histamine release from human gingival mast cells. J Periodontal Res 2001; 36:233–6.

40.

Naesse

Schreurs

Helgeland

Schenck

Steinsvoll

. Matrix metalloproteinases and their inhibitors in gingival mast cells in persons with and without human immunodeficiency virus infection. J Periodontal Res 2003; 38:575–82.

41.

Lee

Wolff

Golub

Sorsa

Kuula

. Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study. Acta Odontol Scand 2008; 66:219–24.

42.

Kivelä-Rajamäki

Maisi

Srinivas

Tervahartiala

Teronen

Husa

Salo

Sorsa

. Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid. J Periodontal Res 2003; 38:583–90.

43.

Mallen-St Clair

Pham

Villalta

Caughey

Wolters

. Mast cell dipeptidyl peptidase I mediates survival from sepsis. J Clin Invest 2004; 113:628–34.

44.

Qiu

Beckman

Qian

Jiranek

. Simultaneous labeling of mast cell proteases and protease mRNAs at the bone-implant interface of aseptically loosened hip implants. J Orthop Res 2005; 23:942–8.

45.

Russo

Peticca

Pietropaolo

Di Rosa

Iuvone

. Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5. Br J Pharmacol 2005; 145:24–33.

46.

Muramatsu

Yamada

Takai

Miyazaki

. Suppression of basic fibroblast growth factor-induced angiogenesis by a specific chymase inhibitor, BCEAB, through the chymase-angiotensin-dependent pathway in hamster sponge granulomas. Br J Pharmacol 2003; 137:554–60.

47.

Huang

Yang

Wang

Pang

. Zinc-chelation contributes to the anti-angiogenic effect of ellagic acid on inhibiting MMP-2 activity, cell migration and tube formation. PLoS One 2011; 6:e18986.